vanilmandelic acid has been researched along with Huntington Disease in 2 studies
Vanilmandelic Acid: A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE.
vanillylmandelic acid : An aromatic ether that is the 3-O-methyl ether of 3,4-dihydroxymandelic acid.
Huntington Disease: A familial disorder inherited as an autosomal dominant trait and characterized by the onset of progressive CHOREA and DEMENTIA in the fourth or fifth decade of life. Common initial manifestations include paranoia; poor impulse control; DEPRESSION; HALLUCINATIONS; and DELUSIONS. Eventually intellectual impairment; loss of fine motor control; ATHETOSIS; and diffuse chorea involving axial and limb musculature develops, leading to a vegetative state within 10-15 years of disease onset. The juvenile variant has a more fulminant course including SEIZURES; ATAXIA; dementia; and chorea. (From Adams et al., Principles of Neurology, 6th ed, pp1060-4)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
McNamee, B | 1 |
Kelvin, AS | 1 |
Turnbull, MJ | 1 |
Tourian, AY | 1 |
1 trial available for vanilmandelic acid and Huntington Disease
Article | Year |
---|---|
Administration of 5-hydroxy-L-tryptophan to individuals with Huntington's chorea.
Topics: 5-Hydroxytryptophan; Adult; Brain; Evaluation Studies as Topic; Female; Humans; Huntington Disease; | 1972 |
1 other study available for vanilmandelic acid and Huntington Disease
Article | Year |
---|---|
Urinary excretion of some monoamines and metabolites in Huntington's chorea.
Topics: Acetates; Adult; Aged; Catecholamines; Epinephrine; Female; Histamine; Humans; Huntington Disease; H | 1971 |